BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6337741)

  • 1. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
    Kramer BL; Massie BM; Topic N
    Circulation; 1983 Apr; 67(4):807-16. PubMed ID: 6337741
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic response to captopril at rest and during exercise in hypertensive patients.
    Fagard R; Lijnen P; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1569-71. PubMed ID: 7041600
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
    Massie B; Kramer BL; Topic N; Henderson SG
    Circulation; 1982 Jun; 65(7):1374-81. PubMed ID: 6280890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
    Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M
    Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
    Packer M; Medina N; Yushak M; Meller J
    Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Kramer B; Topic N; Massie B
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 12. Captopril therapy for heart failure. A placebo controlled study.
    Cowley AJ; Rowley JM; Stainer KL; Hampton JR
    Lancet; 1982 Oct; 2(8301):730-2. PubMed ID: 6125809
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
    Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril in primary pulmonary hypertension.
    Leier CV; Bambach D; Nelson S; Hermiller JB; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Jan; 67(1):155-61. PubMed ID: 6336605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.
    J Am Coll Cardiol; 1983 Oct; 2(4):755-63. PubMed ID: 6350401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined captopril and hydrochlorothiazide therapy in severe hypertension: long-term haemodynamic changes at rest and during exercise.
    Omvik P; Lund-Johansen P
    J Hypertens; 1984 Feb; 2(1):73-80. PubMed ID: 6397525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
    Massie BM; Kramer BL; Topic N
    Circulation; 1984 Jun; 69(6):1135-41. PubMed ID: 6370493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
    Cowley AJ; Rowley JM; Stainer K; Hampton JR
    Lancet; 1984 Nov; 2(8412):1120-4. PubMed ID: 6150183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.